300 related articles for article (PubMed ID: 32427586)
1. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.
Lu H; Xie Y; Tran L; Lan J; Yang Y; Murugan NL; Wang R; Wang YJ; Semenza GL
J Clin Invest; 2020 Sep; 130(9):4607-4623. PubMed ID: 32427586
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
[No Abstract] [Full Text] [Related]
3. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract][Full Text] [Related]
4. NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification.
Yang Y; Chen C; Zuo Q; Lu H; Salman S; Lyu Y; Huang TY; Wicks EE; Jackson W; Datan E; Wang R; Wang Y; Le N; Zhu Y; Qin W; Semenza GL
Sci Adv; 2022 Dec; 8(49):eabo5000. PubMed ID: 36490339
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-Induced Ca
Lu H; Chen I; Shimoda LA; Park Y; Zhang C; Tran L; Zhang H; Semenza GL
Cell Rep; 2017 Feb; 18(8):1946-1957. PubMed ID: 28228260
[TBL] [Abstract][Full Text] [Related]
7. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.
Lu H; Tran L; Park Y; Chen I; Lan J; Xie Y; Semenza GL
Cancer Res; 2018 Aug; 78(15):4191-4202. PubMed ID: 29880481
[TBL] [Abstract][Full Text] [Related]
10. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of S100A10 in metastasized breast cancer stem cells.
Yanagi H; Watanabe T; Nishimura T; Hayashi T; Kono S; Tsuchida H; Hirata M; Kijima Y; Takao S; Okada S; Suzuki M; Imaizumi K; Kawada K; Minami H; Gotoh N; Shimono Y
Cancer Sci; 2020 Dec; 111(12):4359-4370. PubMed ID: 32976661
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment.
Lan J; Lu H; Samanta D; Salman S; Lu Y; Semenza GL
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9640-E9648. PubMed ID: 30242135
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype.
Lu H; Samanta D; Xiang L; Zhang H; Hu H; Chen I; Bullen JW; Semenza GL
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4600-9. PubMed ID: 26229077
[TBL] [Abstract][Full Text] [Related]
14. HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells.
Lu H; Lyu Y; Tran L; Lan J; Xie Y; Yang Y; Murugan NL; Wang YJ; Semenza GL
Cell Rep; 2021 Sep; 36(13):109757. PubMed ID: 34592152
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.
Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.
Xiang L; Semenza GL
Adv Cancer Res; 2019; 141():175-212. PubMed ID: 30691683
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
18. Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model.
Andey T; Marepally S; Patel A; Jackson T; Sarkar S; O'Connell M; Reddy RC; Chellappan S; Singh P; Singh M
J Control Release; 2014 Jun; 184():67-78. PubMed ID: 24727000
[TBL] [Abstract][Full Text] [Related]
19. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
20. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
